Emit Imaging, Inc. will launch a project with the MIT Koch Institute's Preclinical Imaging and Testing Facility to enhance 3D imaging technology. The project will incorporate the Koch Institute’s research-based experiences into cryo-fluorescence tomography (CFT) workflow and method improvements, allowing for greater accuracy and efficiency in studying cancer and other diseases. Emit's CFT technology is a 3D imaging technique that allows for high-resolution, high-sensitivity imaging of biological samples, providing crucial insights into the behavior of drugs and proteins.